Kepos Capital LP Ionis Pharmaceuticals Inc Transaction History

Kepos Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$41.6 - $63.4 $493,417 - $751,987	-11,861 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$53.85 - $65.27 $638,714 - $774,167	11,861 New	11,861 $717,000
Q3 2019 Nov 13, 2019	SELL	$59.06 - $72.15 $1.38 Million - $1.68 Million	-23,293 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$62.09 - $86.14 $1.45 Million - $2.01 Million	23,293 New	23,293 $1.5 Million

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.1B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.